 Flutamide
"Flutamide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antiandrogen with about the same potency as cyproterone in rodent and canine species.
| Descriptor ID |
D005485
|
| MeSH Number(s) |
D02.065.199.420
|
| Concept/Terms |
Chimax- Chimax
- Chiron Brand of Flutamide
Cytamid- Cytamid
- esparma Brand of Flutamide
Eulexin- Eulexin
- Schering-Plough Brand of Flutamide
- Schering Plough Brand of Flutamide
- Eulexine
- Schering Brand of Flutamide
- Drogenil
- Euflex
Fluken- Fluken
- Kendrick Brand of Flutamide
Flulem- Flulem
- Lemery Brand of Flutamide
Flumid- Flumid
- Hexal Brand of Flutamide
Fluta-cell- Fluta-cell
- Fluta cell
- Flutacell
- cell pharm Brand of Flutamide
Fluta-GRY- Fluta-GRY
- Fluta GRY
- FlutaGRY
- Gry Brand of Flutamide
Flutamin- Flutamin
- Alphapharm Brand of Flutamide
Flutaplex- Flutaplex
- Tedec Meiji Brand of Flutamide
Flutexin- Flutexin
- Q-Pharm Brand of Flutamide
- Q Pharm Brand of Flutamide
- Juta Brand of Flutamide
Fugerel- Fugerel
- Essex Brand of Flutamide
Grisetin- Grisetin
- Ipsen Brand of Flutamide
Novo-Flutamide- Novo-Flutamide
- Novo Flutamide
- NovoFlutamide
- Novopharm Brand of Flutamide
Oncosal- Oncosal
- Inibsa Brand of Flutamide
PMS-Flutamide- PMS-Flutamide
- PMS Flutamide
- Pharmascience Brand of Flutamide
Prostacur- Prostacur
- Prasfarma Brand of Flutamide
Testotard- Testotard
- Chephasaar Brand of Flutamide
Apimid- Apimid
- Apogepha Brand of Flutamide
Apo-Flutamide- Apo-Flutamide
- Apo Flutamide
- ApoFlutamide
- Apotex Brand of Flutamide
|
Below are MeSH descriptors whose meaning is more general than "Flutamide".
Below are MeSH descriptors whose meaning is more specific than "Flutamide".
This graph shows the total number of publications written about "Flutamide" by people in this website by year, and whether "Flutamide" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 | | 2002 | 0 | 2 | 2 | | 2003 | 0 | 1 | 1 | | 2004 | 0 | 1 | 1 | | 2005 | 0 | 1 | 1 | | 2008 | 1 | 1 | 2 | | 2009 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Flutamide" by people in Profiles.
-
Nguyen PL, Chen MH, Beard CJ, Suh WW, Renshaw AA, Loffredo M, McMahon E, Kantoff PW, D'Amico AV. Radiation with or without 6 months of androgen suppression therapy in intermediate- and high-risk clinically localized prostate cancer: a postrandomization analysis by risk group. Int J Radiat Oncol Biol Phys. 2010 Jul 15; 77(4):1046-52.
-
D'Amico AV, Chen MH, Renshaw AA, Loffredo M, Kantoff PW. Interval to testosterone recovery after hormonal therapy for prostate cancer and risk of death. Int J Radiat Oncol Biol Phys. 2009 Sep 01; 75(1):10-5.
-
D'Amico AV, Chen MH, Renshaw AA, Loffredo B, Kantoff PW. Risk of prostate cancer recurrence in men treated with radiation alone or in conjunction with combined or less than combined androgen suppression therapy. J Clin Oncol. 2008 Jun 20; 26(18):2979-83.
-
D'Amico AV, Chen MH, Renshaw AA, Loffredo M, Kantoff PW. Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial. JAMA. 2008 Jan 23; 299(3):289-95.
-
Johnke RM, Edwards JM, Kovacs CJ, Evans MJ, Daly BM, Karlsson UL, Lee TK, Allison RR, Arastu HH, Cariveau MJ, O'Brien KF. Response of T lymphocyte populations in prostate cancer patients undergoing radiotherapy: influence of neoajuvant total androgen suppression. Anticancer Res. 2005 Jul-Aug; 25(4):3159-66.
-
D'Amico AV, Manola J, Loffredo M, Renshaw AA, DellaCroce A, Kantoff PW. 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. JAMA. 2004 Aug 18; 292(7):821-7.
-
Rao MK, Wayne CM, Meistrich ML, Wilkinson MF. Pem homeobox gene promoter sequences that direct transcription in a Sertoli cell-specific, stage-specific, and androgen-dependent manner in the testis in vivo. Mol Endocrinol. 2003 Feb; 17(2):223-33.
-
Weihua Z, Ekman J, Almkvist A, Saji S, Wang L, Warner M, Gustafsson JA. Involvement of androgen receptor in 17beta-estradiol-induced cell proliferation in rat uterus. Biol Reprod. 2002 Aug; 67(2):616-23.
-
Cheng G, Weihua Z, Mäkinen S, Mäkelä S, Saji S, Warner M, Gustafsson JA, Hovatta O. A role for the androgen receptor in follicular atresia of estrogen receptor beta knockout mouse ovary. Biol Reprod. 2002 Jan; 66(1):77-84.
-
Renshaw AA, Granter SR. Metastatic, sarcomatoid, and PSA- and PAP-negative prostatic carcinoma: diagnosis by fine-needle aspiration. Diagn Cytopathol. 2000 Sep; 23(3):199-201.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|